tenk.fyi

Voyager Therapeutics, Inc.

VYGRNasdaq· Biological Products, (No Diagnostic Substances)

Price History

Revenue

$40.4M

49.5% YoY

Net Income

-$119.7M

84.2% YoY

EPS

$-2.04

80.5% YoY

Cash

$65.3M

8.5% YoY

FY 2025 · As of 2025-12-31